To preli
minarily inves
tiga
te
the possible role of pros
taglandin D
2 (PGD
2) in
malaria infec
tions.
Methods
Blood and urinary samples (m>nm> = 120 each) were collected from Thai patients with m>Plasmodium falciparumm> (m>P. falciparumm>) with moderate (m>nm> = 26) and high (m>nm> = 4) parasitemia, patients with m>Plasmodium vivaxm> (m>P. vivaxm>) (m>nm> = 30), patients with fever associated with other infections (m>nm> = 30), and healthy subjects (m>nm> = 30). PGD2 concentrations in plasma and urinary samples of healthy subjects, patients with fever associated with other infections and patients with malaria were determined using Prostaglandin D2-MOX express EIA kit (Cayman Chemical, USA).
Results
The possible association between PGD2 and malaria infections is clearly demonstrated with PGD2 concentration in urine. The urinary PGD2 concentrations were relatively high (about 5-fold) in patients with m>P. falciparumm> with moderate parasitemia and m>P. vivaxm> infections compared with other groups. Furthermore, the concentration in patients with m>P. falciparumm> with moderate parasitemia and m>P. vivaxm> infection were significantly higher than that in healthy subjects and patients with fever associated with other infections.
Conclusions
Urinary PGD2 concentrations may offer a more dependable and useful tool for predicting malaria severity. Confirmation is this preliminary finding is required with a larger sample size.